Accuracy of sentinel lymph node biopsy in patients with large primary breast tumors

Cancer

Volumn 88, Issue 11, 2000, Pages 2540-2545

  Bedrosian, Isabelle ^a   Reynolds, Carol ^b   Mick, Rosemarie ^c   Callans, Linda S ^a   Grant, Clive S ^b   Donohue, John H ^b   Farley, David R ^b   Heller, Rose ^c   Conant, Emily ^c   Orel, Susan G ^c   Lawton, Thomas ^a   Fraker, Douglas L ^a   Czerniecki, Brian J ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Axillary staging; Breast carcinoma; Neoadjuvant chemotherapy; Sentinel lymph node biopsy; Surgery

Indexed keywords

ANTIINFECTIVE AGENT;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST TUMOR; CANCER STAGING; CANCER SURGERY; DIAGNOSTIC ACCURACY; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR BIOPSY; TUMOR DIAGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BIOPSY; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CONFIDENCE INTERVALS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PILOT PROJECTS;

EID: 0034213461     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20000601)88:11<2540::AID-CNCR16>3.0.CO;2-A     Document Type: Article

References (29)

1. Kantarjian H, Hortobagyi G, Smith T, Blumenschein GR, Montague E, Buzdar AU, et al. The management of locally advanced breast cancer: a combined modality approach. Eur J Cancer Clin Oncol 1984;20:1353-61.
2. Bonadonna G, Veronesi U, Brambilla C, Ferrari L, Luini A, Greco M, et al. Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more. J Natl Cancer Inst 1990;82:1539-45.
3. Fisher B, Brown A, Mamounas E, Wieand S, Robidoux A, Margolese RG, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997;15:2483-93.
4. Schwartz GF, Birchansky CA, Komarnicky LT, Mansfield CM, Cantor RI, Biermann WA, et al. Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 1994;73:362-9.
5. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M. The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynecol Obstet 1981;152:765-72.
6. Bonnema J, van Geel AN, van Ooijen B, Mali SPM, Tijam SL, Henzen-Logmans SC, et al. Ultrasound-guided aspiration biopsy for detection of non-palpable axillary node metastasis in breast cancer patients: new diagnostic method. World J Surg 1997;21:270-4.
7. Crippa F, Agresti H, Seregni E, Greco M, Pascali C, Bogni A, et al. Prospective evaluation of fluorine-18-fdg pet in presurgical staging of the axilla in breast cancer. J Nucl Med 1998;39:4-8.
8. Smith IC, Ogston KN, Whitford P, Smith FW, Sharp P, Norton M, et al. Staging of the axilla in breast cancer: accurate in vivo assessment using positron emission tomography with 2-(fluorine-18)-fluor-2-deoxy-D-glucose. Ann Surg 1998;228:220-7.
9. Morton D, Wen D, Wong J, Economou S, Cagle L, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
10. Albertini I, Cruse C, Rapaport D, Wells K, Ross M, DeConti R, et al. Intraoperative radiolymphoscintography improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217-24.
11. Krag D, Meijer S, Weaver D, Loggie BW, Harlow SP, Tanabe KK, et al. Minimal access surgery for staging of malignant melanoma. Arch Surg 1995;130:654-8.
12. Pijpers R, Collet G, Meijer S, Hoekstra O. The impact of dynamic lymphoscintography and gamma probe guidance on sentinel node biopsy in melanoma. Eur J Nucl Med 1995;22:1238-41.
13. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
14. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15: 2345-50.
15. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EFI, Boom RPA, et al. Impact of lymphoscintigraphy on sentinel node identification with technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1996;38:366-8.
16. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864-7.
17. Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, et al. The sentinel node in breast cancer-a multicenter validation study. N Engl J Med 1998;339:941-6.
18. Czerniecki BJ, Scheff AM, Callans LS, Spitz FR, Bedrosian I, Conant EF, et al. Immunohistochemistry with pancytokeratins improves the sensitivity of sentinel node biopsy in patients with breast cancer. Cancer 1999;85:1098-103.
19. O'Hea BJ, Hill AD, El-Shirbiny AM, Yeh SDJ, Rosen PP, Coit DG, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Ketering Cancer Center. J Am Coll Surg 1998;186:423-7.
20. Bedrosian I, Scheff AM, Mick R, Callans LS, Bucky LP, Spitz FR, et al. Technetium-99m human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma. J Nucl Med 1999;40:1143-8.
21. Reynolds C, Mick R, Donohue JH, Grant CS, Orel SG, Keeney GL, et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J Clin Oncol 1999;17:1720-6.
22. Turner RR, Ollila DW, Krasne DL, Giulano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;226:271-8.
23. Cunningham JD, Weiss SE, Ahmed S, Bratton JM, Bleiweiss IJ, Tattler PI, et al. The efficacy of neoadjuvant chemotherapy to compared to postoperative therapy in the treatment of locally advanced breast cancer. Cancer Invest 1998;16:80-6.
24. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. Jo Clin Oncol 1998;16:2672-85.
25. Kling KM, Ostrzega N, Schmit P. Breast conservation after induction chemotherapy for locally advanced breast cancer. Am Surg 1997;63:861-4.
26. Kuerer HM, Newman LA, Fornage BD, Dhingra K, Hunt KK, Buzdar AU, et al. Role of axillary lymph node dissection after tumor downstaging with induction chemtherapy for locally advanced breast cancer. Ann Surg Oncol 1998;5:673-80.
27. McCready DR, Hortobagyi GN, Kau SW, Smith TL, Buzdar AU, Balch CM. The prognostic significance of lymph node metastasis after preoperative chemotherapy for locally advanced breast cancer. Arch Surg 1988;124:21-5.
28. Botti C, Vici P, Lopez M, Scinto AF, Cognetti F, Cavaliere R. Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast. J Am Coll Surg 1995;188:202-8.
29. Chu K, Turner R, Hansen N, Brennan M, Bilchik A, Giuliano A. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection? Ann Surg 1999;229:536-41.